Cefuroxime how supplied

Revision as of 05:09, 5 January 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Cefuroxime}} {{CMG}};{{AE}}{{AK}} ZINACEF in the dry state should be stored between 15° and 30°C (59° and 86°F) and protected from light. ZINACEF is a dry, wh...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cefuroxime
ZINACEF®,CEFUROXIME® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Compatibility and Stability
Direction For Use
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

ZINACEF in the dry state should be stored between 15° and 30°C (59° and 86°F) and protected from light. ZINACEF is a dry, white to off-white powder supplied in vials as follows:

NDC 0173-0352-10 750-mg* Vial (Tray of 10)

NDC 0173-0354-10 1.5-g* Vial (Tray of 10)

NDC 0173-0400-00 7.5-g* Pharmacy Bulk Package (Tray of 6)

NDC 0173-0436-00 750-mg ADD-Vantage Vial (Tray of 25)

NDC 0173-0437-00 1.5-g ADD-Vantage Vial (Tray of 10)

(The above ADD-Vantage vials are to be used only with Abbott ADD-Vantage diluent containers.)

ZINACEF frozen as a premixed solution of cefuroxime injection should not be stored above -20°C. ZINACEF is supplied frozen in 50-mL, single-dose, plastic containers as follows:

NDC 0173-0424-00 750-mg* Plastic Container (Carton of 24)

NDC 0173-0425-00 1.5-g* Plastic Container (Carton of 24)

  • Equivalent to cefuroxime.


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/50643s11lbl.pdf